
Establishment Labs Holdings ESTA
$ 70.23
2.33%
Annual report 2025
added 02-27-2026
Country |
|
IPO year |
2018 |
Industry |
Medical devices |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
29.6 M |
Market Cap[1] |
$ 2.08 B |
EBITDA (LTM) |
$ -42.2 M |
P/E (LTM) |
-30.64 |
P/S (LTM) |
10.89 |
EPS (LTM) |
-2.24 |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
AdaptHealth Corp.
AHCO
|
$ 13.17 | 0.46 % | $ 1.78 B | Nasdaq Capital Market | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Eargo
EAR
|
- | - | $ 10.2 M | Nasdaq Global Select Market,SPB | ||
|
Delcath Systems
DCTH
|
$ 10.8 | 4.05 % | $ 387 M | Nasdaq Capital Market | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
Electromed
ELMD
|
$ 25.6 | -0.43 % | $ 216 M | NYSE American | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
EDAP TMS S.A.
EDAP
|
$ 3.47 | 4.52 % | $ 130 M | Nasdaq Global Market | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
Helius Medical Technologies
HSDT
|
$ 2.12 | 3.92 % | $ 1.29 M | Nasdaq Capital Market | ||
|
Inspire Medical Systems
INSP
|
$ 56.7 | 1.0 % | $ 1.67 B | NYSE,SPB | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
LivaNova PLC
LIVN
|
$ 61.0 | 1.5 % | $ 3.33 B | Nasdaq Global Select Market | ||
|
ClearPoint Neuro
CLPT
|
$ 11.37 | 1.7 % | $ 322 M | Nasdaq Capital Market | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.61 | 0.36 % | $ 38 M | Nasdaq Capital Market | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
IRIDEX Corporation
IRIX
|
$ 1.03 | - | $ 17.4 M | Nasdaq Global Select Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 15.65 | 3.92 % | $ 367 M | Nasdaq Global Select Market,SPB | ||
|
Butterfly Network
BFLY
|
$ 5.4 | 12.97 % | $ 1.14 B | NYSE | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | ||
|
Sintx Technologies
SINT
|
$ 2.41 | 14.22 % | $ 6.68 M | Nasdaq Capital Market | ||
|
Globus Medical
GMED
|
$ 91.34 | 1.29 % | $ 12.4 B | NYSE,SPB | ||
|
TransMedics Group
TMDX
|
$ 100.01 | -0.77 % | $ 3.4 B | Nasdaq Global Market | ||
|
NanoVibronix
NAOV
|
- | - | $ 1.08 M | Nasdaq Global Select Market | ||
|
CONMED Corporation
CNMD
|
$ 36.8 | 0.38 % | $ 1.14 B | NYSE,SPB | ||
|
Integer Holdings Corporation
ITGR
|
$ 84.03 | -5.06 % | $ 2.92 B | NYSE,SPB | ||
|
Stryker Corporation
SYK
|
$ 294.73 | -6.47 % | $ 113 B | NYSE,SPB | ||
|
Edwards Lifesciences Corporation
EW
|
$ 83.98 | 0.57 % | $ 49.1 B | NYSE,SPB | ||
|
Tandem Diabetes Care
TNDM
|
$ 19.41 | -0.61 % | $ 1.32 B | Nasdaq Global Market,SPB | ||
|
LENSAR
LNSR
|
$ 5.61 | 7.27 % | $ 67.1 M | Nasdaq Capital Market | ||
|
Pulmonx Corporation
LUNG
|
$ 1.35 | 5.47 % | $ 54.9 M | Nasdaq Global Select Market | ||
|
MiMedx Group
MDXG
|
$ 3.68 | 9.52 % | $ 544 M | Nasdaq Global Select Market | ||
|
Myomo
MYO
|
$ 0.9 | 4.16 % | $ 37.7 M | NYSE American |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.